Ying Huang

Closest collaborators

The 25 strongest of 68 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Randall E. Brand · 9 shared papers, 2015–2025 · strength 0.93
   • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
   • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
   • Paper Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. DOI 10.1158/1940-6207.capr-20-0303↗
2. Brian B. Haab · 7 shared papers, 2015–2025 · strength 0.76
   • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
   • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
   • Paper Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDR… DOI 10.1158/1055-9965.epi-20-0161↗
3. Anirban Maitra · 5 shared papers, 2019–2024 · strength 0.60
   • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
   • Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
   • Paper Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. DOI 10.1158/1940-6207.capr-20-0303↗
4. Aatur Dilip Singhi · 5 shared papers, 2017–2025 · strength 0.56
   • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
   • Paper Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDR… DOI 10.1158/1055-9965.epi-20-0161↗
   • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
5. Ben Staal · 4 shared papers, 2019–2025 · strength 0.55
   • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
   • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
   • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
6. Sudhir Srivastava · 5 shared papers, 2015–2024 · strength 0.43
   • Paper Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer. DOI 10.1007/s00535-023-02072-w↗
   • Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
   • Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
7. ChongFeng Gao · 3 shared papers, 2019–2025 · strength 0.38
   • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
   • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
   • Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
8. Jo Ann Rinaudo · 4 shared papers, 2015–2022 · strength 0.32
   • Paper Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyper… DOI 10.1016/j.cct.2021.106659↗
   • Paper Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDR… DOI 10.1158/1055-9965.epi-20-0161↗
   • Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
9. Peter J. Allen · 2 shared papers, 2021–2025 · strength 0.30
   • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
   • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
10. Johannes Francois Fahrmann · 2 shared papers, 2020–2024 · strength 0.27
    • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
    • Paper Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDR… DOI 10.1158/1055-9965.epi-20-0161↗
11. Samir Hanash · 2 shared papers, 2020–2024 · strength 0.27
    • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
    • Paper Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDR… DOI 10.1158/1055-9965.epi-20-0161↗
12. Surinder K. Batra · 2 shared papers, 2020–2024 · strength 0.27
    • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗
    • Paper Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDR… DOI 10.1158/1055-9965.epi-20-0161↗
13. Daniel Barnett · 3 shared papers, 2017–2021 · strength 0.25
    • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
    • Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
    • Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
14. Richard R. Drake · 3 shared papers, 2017–2021 · strength 0.25
    • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
    • Paper The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. DOI 10.1158/1078-0432.ccr-18-3310↗
    • Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
15. Subrata Sen · 3 shared papers, 2015–2021 · strength 0.21
    • Paper Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. DOI 10.1158/1940-6207.capr-20-0303↗
    • Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
    • Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
16. Ann McNeill Killary · 3 shared papers, 2015–2021 · strength 0.21
    • Paper Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. DOI 10.1158/1940-6207.capr-20-0303↗
    • Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
    • Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
17. Braelyn Binkowski · 1 shared paper, 2025 · strength 0.20
    • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
18. Chanjuan Shi · 1 shared paper, 2025 · strength 0.20
    • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
19. Steve Gallinger · 1 shared paper, 2025 · strength 0.20
    • Paper Multiplexed glycan immunofluorescence identification of pancreatic cancer cell subpopulations in both tumor and blood s… DOI 10.1126/sciadv.adt0029↗
20. Michimoto Kobayashi · 2 shared papers, 2015–2024 · strength 0.19
    • Paper Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer. DOI 10.1007/s00535-023-02072-w↗
    • Paper Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibo… DOI 10.1038/srep15921↗
21. Kazufumi Honda · 2 shared papers, 2015–2024 · strength 0.19
    • Paper Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer. DOI 10.1007/s00535-023-02072-w↗
    • Paper Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibo… DOI 10.1038/srep15921↗
22. Giman Jung · 2 shared papers, 2015–2024 · strength 0.19
    • Paper Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer. DOI 10.1007/s00535-023-02072-w↗
    • Paper Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibo… DOI 10.1038/srep15921↗
23. Suyu Liu · 2 shared papers, 2017–2021 · strength 0.17
    • Paper Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. DOI 10.1158/1940-6207.capr-20-0303↗
    • Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
24. Ying Liu · 2 shared papers, 2017–2021 · strength 0.17
    • Paper Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. DOI 10.1158/1078-0432.ccr-20-2475↗
    • Paper The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells. DOI 10.1038/s41598-017-04164-z↗
25. Christine Worthington · 1 shared paper, 2024 · strength 0.16
    • Paper A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9… DOI 10.1016/j.canlet.2024.217245↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.